190 related articles for article (PubMed ID: 17970044)
61. Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt.
Ismail MF; El Boghdady NA; Shabayek MI; Awida HA; Abozeed H
Tumour Biol; 2016 Apr; 37(4):4621-31. PubMed ID: 26508026
[TBL] [Abstract][Full Text] [Related]
62. Loss of p63 expression is associated with tumor progression in bladder cancer.
Urist MJ; Di Como CJ; Lu ML; Charytonowicz E; Verbel D; Crum CP; Ince TA; McKeon FD; Cordon-Cardo C
Am J Pathol; 2002 Oct; 161(4):1199-206. PubMed ID: 12368193
[TBL] [Abstract][Full Text] [Related]
63. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers.
Cross SS; Hamdy FC; Deloulme JC; Rehman I
Histopathology; 2005 Mar; 46(3):256-69. PubMed ID: 15720411
[TBL] [Abstract][Full Text] [Related]
64. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.
Izawa JI; Slaton JW; Kedar D; Karashima T; Perrotte P; Czerniak B; Grossman HB; Dinney CP
Oncol Rep; 2001; 8(1):9-15. PubMed ID: 11115562
[TBL] [Abstract][Full Text] [Related]
65. Metallothionein isoform 3 as a potential biomarker for human bladder cancer.
Sens MA; Somji S; Lamm DL; Garrett SH; Slovinsky F; Todd JH; Sens DA
Environ Health Perspect; 2000 May; 108(5):413-8. PubMed ID: 10811567
[TBL] [Abstract][Full Text] [Related]
66. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
67. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
68. Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer.
Cui L; Wang Y; Shi Y; Zhang Z; Xia Y; Sun H; Wang S; Chen J; Zhang W; Lu Q; Song L; Wei Q; Zhang R; Wang X
Proteomics; 2007 Nov; 7(22):4192-202. PubMed ID: 17994624
[TBL] [Abstract][Full Text] [Related]
69. Gastric cancers overexpress S100A calcium-binding proteins.
El-Rifai W; Moskaluk CA; Abdrabbo MK; Harper J; Yoshida C; Riggins GJ; Frierson HF; Powell SM
Cancer Res; 2002 Dec; 62(23):6823-6. PubMed ID: 12460893
[TBL] [Abstract][Full Text] [Related]
70. Overexpression of the wild type p73 gene in human bladder cancer.
Yokomizo A; Mai M; Tindall DJ; Cheng L; Bostwick DG; Naito S; Smith DI; Liu W
Oncogene; 1999 Feb; 18(8):1629-33. PubMed ID: 10102633
[TBL] [Abstract][Full Text] [Related]
71. ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma.
Gunes S; Sullu Y; Yegin Z; Buyukalpelli R; Tomak L; Bagci H
Pathol Res Pract; 2013 Feb; 209(2):99-104. PubMed ID: 23333248
[TBL] [Abstract][Full Text] [Related]
72. Co-expression/co-location of S100 proteins (S100B, S100A1 and S100A2) and protein kinase C (PKC-beta, -eta and -zeta) in a rat model of cerebral basilar artery vasospasm.
Lefranc F; Decaestecker C; Brotchi J; Heizmann CW; Dewitte O; Kiss R; Mijatovic T
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):649-60. PubMed ID: 16281914
[TBL] [Abstract][Full Text] [Related]
73. Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction.
Meyers FJ; Gumerlock PH; Kawasaki ES; Wang AM; deVere White RW; Erlich HA
Cancer; 1991 Apr; 67(8):2087-95. PubMed ID: 2004327
[TBL] [Abstract][Full Text] [Related]
74. Rat urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and N-methyl-N-nitrosourea.
Ozono S; Babaya K; Sasaki K; Okamoto S; Momose H; Fujimoto K; Tsumatani K; Yamaguchi H; Hirao Y; Okajima E
Urol Res; 1990; 18(5):323-6. PubMed ID: 2256233
[TBL] [Abstract][Full Text] [Related]
75. Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
Hussein S; Mosaad H; Rashed HE; Ahmed S; Ragab A; Ismail EI
Mol Biol Rep; 2017 Aug; 44(4):365-377. PubMed ID: 28808805
[TBL] [Abstract][Full Text] [Related]
76. L-Leucine and L-isoleucine enhance growth of BBN-induced urothelial tumors in the rat bladder by modulating expression of amino acid transporters and tumorigenesis-associated genes.
Xie XL; Kakehashi A; Wei M; Yamano S; Takeshita M; Yunoki T; Wanibuchi H
Food Chem Toxicol; 2013 Sep; 59():137-44. PubMed ID: 23747718
[TBL] [Abstract][Full Text] [Related]
77. Prognostic significance of heme oxygenase-1, S100 calcium-binding protein A4, and syndecan-1 expression in primary non-muscle-invasive bladder cancer.
Kim JH; Park J
Hum Pathol; 2014 Sep; 45(9):1830-8. PubMed ID: 24957789
[TBL] [Abstract][Full Text] [Related]
78. Modulation of quaternary structure of S100 proteins by calcium ions.
Streicher WW; Lopez MM; Makhatadze GI
Biophys Chem; 2010 Oct; 151(3):181-6. PubMed ID: 20621410
[TBL] [Abstract][Full Text] [Related]
79. p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Don I; Takada N; Ogawa K; Shirai T; Fukushima S
Carcinogenesis; 1994 Oct; 15(10):2379-81. PubMed ID: 7955081
[TBL] [Abstract][Full Text] [Related]
80. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
Dyrskjøt L; Kruhøffer M; Thykjaer T; Marcussen N; Jensen JL; Møller K; Ørntoft TF
Cancer Res; 2004 Jun; 64(11):4040-8. PubMed ID: 15173019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
